By Danielle Peter Marks, the former head of the FDA’s Center for Biologics Evaluation and Research (CBER) and a prominent critic of Health and Human Services…
By Danielle Peter Marks, the former head of the FDA’s Center for Biologics Evaluation and Research (CBER) and a prominent critic of Health and Human Services…